Back to Search Start Over

Supplementary Figure Legends from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....5f1c44f2f9184d5d626b2b8a51d54fdd